Total Valuation
Clover Health Investments has a market cap or net worth of €2.11B. The enterprise value is €2.86K.
Market Cap€2.11B
Enterprise Value€2.86K
Share Statistics
Clover Health Investments has 435,441,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding435,441,350
Owned by Insiders6.85%
Owned by Institutions1.21%
Financial Efficiency
Clover Health Investments’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -25.75%.
Return on Equity (ROE)-0.28
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-25.75%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee2.66M
Profits Per Employee-118.16K
Employee Count724
Asset Turnover3.56
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Clover Health Investments is ―. Clover Health Investments’s PEG ratio is -0.15.
PE Ratio―
PS Ratio0.63
PB Ratio3.94
Price to Fair Value3.94
Price to FCF-17.62
Price to Operating Cash Flow30.89
PEG Ratio-0.15
Income Statement
In the last 12 months, Clover Health Investments had revenue of 1.92B and earned -85.55M in profits. Earnings per share was -0.17.
Revenue1.92B
Gross Profit355.88M
Operating Income-85.53M
Pretax Income-85.55M
Net Income-85.55M
EBITDA-83.86M
Earnings Per Share (EPS)-0.17
Cash Flow
In the last 12 months, operating cash flow was 77.03M and capital expenditures -2.83M, giving a free cash flow of 74.21M billion.
Operating Cash Flow77.03M
Free Cash Flow74.21M
Free Cash Flow per Share0.17
Dividends & Yields
Clover Health Investments pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change55.88%
50-Day Moving Average3.76
200-Day Moving Average2.76
Relative Strength Index (RSI)58.61
Average Volume (3m)30.00
Important Dates
Clover Health Investments upcoming earnings date is Nov 9, 2026, After Close (Confirmed).
Last Earnings DateAug 5, 2026
Next Earnings DateNov 9, 2026
Ex-Dividend Date―
Financial Position
Clover Health Investments as a current ratio of 1.47, with Debt / Equity ratio of 0.00%
Current Ratio1.47
Quick Ratio1.47
Debt to Market Cap0.00
Net Debt to EBITDA0.93
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Clover Health Investments has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Clover Health Investments EV to EBITDA ratio is -13.56, with an EV/FCF ratio of -16.49.
EV to Sales0.59
EV to EBITDA-13.56
EV to Free Cash Flow-16.49
EV to Operating Cash Flow-16.99
Balance Sheet
Clover Health Investments has €201.32M in cash and marketable securities with €0.00 in debt, giving a net cash position of €201.32M billion.
Cash & Marketable Securities€201.32M
Total Debt€0.00
Net Cash€201.32M
Net Cash Per Share€0.46
Tangible Book Value Per Share€0.59
Margins
Gross margin is 18.57%, with operating margin of -4.44%, and net profit margin of -4.45%.
Gross Margin18.57%
Operating Margin-4.44%
Pretax Margin-4.45%
Net Profit Margin-4.45%
EBITDA Margin-4.36%
EBIT Margin-4.45%
Analyst Forecast
The average price target for Clover Health Investments is €4.77, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€4.77
Price Target Upside22.29% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast43.69%
EPS Growth Forecast60.08%